• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (6)
    • Glottis
    • Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.
    • Tilt-Table Test
    • TNF Receptor-Associated Factor 2
    • Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision.
    • See All 6 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision.

Recombinant human thrombin: safety and immunogenicity in pediatric burn wound excision. J Pediatr Surg. 2011 Oct; 46(10):1992-9.

View in: PubMed

subject areas
  • Administration, Topical
  • Adolescent
  • Anemia
  • Blood Loss, Surgical
  • Burns
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Enzyme-Linked Immunosorbent Assay
  • Epinephrine
  • Female
  • Hemostatic Techniques
  • Hemostatics
  • Humans
  • Infant
  • Isoantibodies
  • Male
  • Pain
  • Postoperative Complications
  • Postoperative Hemorrhage
  • Pruritus
  • Recombinant Proteins
  • Skin Transplantation
  • Thrombin

authors with profiles
  • Steven A Kahn